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Abstract
Hepatitis C virus (HCV) infects 170 million people worldwide, and is a major public health problem in Brazil, where over 1%
of the population may be infected and where multiple viral genotypes co-circulate. Chronically infected individuals are both
the source of transmission to others and are at risk for HCV-related diseases, such as liver cancer and cirrhosis. Before the
adoption of anti-HCV control measures in blood banks, this virus was mainly transmitted via blood transfusion. Today,
needle sharing among injecting drug users is the most common form of HCV transmission. Of particular importance is that
HCV prevalence is growing in non-risk groups. Since there is no vaccine against HCV, it is important to determine the factors
that control viral transmission in order to develop more efficient control measures. However, despite the health costs
associated with HCV, the factors that determine the spread of virus at the epidemiological scale are often poorly
understood. Here, we sequenced partial NS5b gene sequences sampled from blood samples collected from 591 patients in
Sa ˜o Paulo state, Brazil. We show that different viral genotypes entered Sa ˜o Paulo at different times, grew at different rates,
and are associated with different age groups and risk behaviors. In particular, subtype 1b is older and grew more slowly
than subtypes 1a and 3a, and is associated with multiple age classes. In contrast, subtypes 1a and 3b are associated with
younger people infected more recently, possibly with higher rates of sexual transmission. The transmission dynamics of HCV
in Sa ˜o Paulo therefore vary by subtype and are determined by a combination of age, risk exposure and underlying social
network. We conclude that social factors may play a key role in determining the rate and pattern of HCV spread, and should
influence future intervention policies.
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Introduction
Hepatitis C virus (HCV) is a major cause of hepatitis and liver
cancer globally, chronically infecting nearly 3% of the world’s
population [1]. During the second half of the 20
th Century, the
global HCV pandemic worsened due to widespread viral
transmission by blood or blood-derived products, and by unsafe
medical practices. Today, needle sharing among injecting drug
users (IDUs) is a major risk factor in industrialized countries [2]
and prevalence among IDUs ranges from 30 to 90% [3,4], with
between 5.6 to 36% of Brazilian drug users infected [5].
Approximately 15–40% of infected persons clear the virus during
the acute phase. Of the remainder, nearly 80% result in chronic
infections which may lead to subsequent viral transmission [6]. It
has been estimated that 0.8% to 3.5% of the Brazilian population
is HCV-positive, while prevalence among those that are also HIV
infected may reach 25% [7].
HCV is classified into six major genotypes and many subtypes,
varying in geographical distribution, transmission route and
treatment response [1,8,9]. Genotype 1, and especially subtypes
1a and 1b, are the most prevalent worldwide, although 1b is
mostly found among older members of the population who have a
history of blood transfusion [3,10,11]. HCV-1a and 3a appear to
have emerged recently and are spreading rapidly in many global
regions, with a high prevalence among young IDUs [3,10,11,12].
Coarse-grained phylogenetic studies suggest that HCV subtypes 1a
and 1b reached a plateau globally in the 1980’s after previously
experiencing exponential growth [13]. Despite the increasing
importance of HCV for human health, no vaccine is currently
available, treatment is suboptimal in many countries and,
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cause [14]. Moreover, there is a severe lack of donor organs,
causing tens of thousands of patients with decompensate liver
disease and portal hypertension to await orthotopic liver
transplantation [15].
The lack of an effective vaccine highlights that prevention is
currently the main strategy available to control viral transmission.
As a consequence, detailed studies of the molecular epidemiology
of HCV, particularly at the scale of local epidemics, are needed to
enhance our understanding of the transmission dynamics of this
major public health problem. Herein, we investigated the
population dynamics of HCV in the most populous region of
Brazil – Sa ˜o Paulo state – with the aim of identifying the
epidemiological factors that influence viral transmission.
Materials and Methods
Experimental design
Partial NS5b gene sequences were obtained from blood samples
collected from 591 patients chosen irrespective of their risk
associations between 1997 and 2006 as part of the Viral Genetic
Diversity Network (VGDN) program [16]. Patients were sampled
from four different regions within Sa ˜o Paulo state; Ribeira ˜o Preto,
Sa ˜o Jose ´ do Rio Preto, Sa ˜o Bernardo do Campo and from two
reference centers for HCV surveillance and treatment in Sa ˜o Paulo
city (Clı ´nicas Hospital and Reference and Training Center- RTC).
After RNA extraction from blood samples and cDNA synthesis, a
361 nt region of NS5b was amplified. Questionnaire data from
patients such as age, gender, sex, and marital state were collected at
the time of sampling. Relevant clinical information on transmission
risk factors was gathered, including: (i) self-declared drug use profile:
injected (IDU)ornon-injecteddrugs(crackand cocaine) (NIDU), (ii)
sexual behavior, including the number of casual and regular sexual
partners during their entire life and, (iii) blood transfusion (BT)
before and after 1993 when HCV blood screening started in Brazil,
were also obtained. The NS5b sequences were typed by phy-
logenetic inference with the inclusion of worldwide HCV reference
sequences available in GenBank (http://www.ncbi.nlm.nih.gov/
Genbank/) and Los Alamos HCV database (hcv.lanl.gov/). All
sequences generated here have been deposited in GenBank and
assigned accession numbers GQ490493–GQ491027.
Ethics Statements
All procedures adopted in this work were done according to the
terms agreed by the Ethics Committee on Human Research of the
University of Sa ˜o Paulo and informed consent terms were signed
by all patients.
Inferring phylogenetic history
NS5b sequences were aligned using Clustal X [17]. Phyloge-
netic trees were inferred using the GARLi program (Genetic
Algorithm for Rapid Likelihood Inference) [18], which employs an
extensive branch-swapping protocol and optimizes the substitution
model iteratively during the search. Initial trees were used to
determine the position of our sequences in the context of the
global HCV pandemic. In particular, these analyses allowed us to
identify and eliminate sequences that were directly related to non-
Brazilian sequences suggesting that they had been imported from
localities outside of Brazil.
HCV phylodynamics
To investigate the population history of HCV in Sa ˜o Paulo state
(after excluding potential migrants) we utilized the Bayesian
Markov Chain Monte Carlo (MCMC) approach implemented in
the BEAST package [19]. First, the rate of nucleotide substitution
as well as the Time to the Most Recent Common Ancestor
(TMRCA) of each viral subtype was estimated under the best-fit
model of nucleotide substitution obtained by comparing the
GTR+C+I, GTR+C+I+SRD112, HKY and HKY+SRD112 models
[20] using Bayes factors (BF) (although similar results were
obtained under all substitution models). We also utilized both strict
and relaxed (uncorrelated lognormal) molecular clocks. To be as
conservative as possible we also employed the least constrained
Bayesian skyline coalescent prior, which provided similar substi-
tution rates to those obtained with the best demographic model for
each subtype. To improve the MCMC search, we set the operator
values as a function of the number of taxa in each group, and set
the upper value of the ‘population size’ parameter to 170 million,
which hypothetically covers the estimated number of infected
people in the world. After optimizing the values of the MCMC
operators during preliminary runs, up to 10 additional MCMC
runs, each consisting of 20 million generations (with a 50%
burnin), were undertaken to obtain convergence of parameter
estimates. With the substitution rates in place we then estimated
the rate of population growth (r) under the demographic model
(i.e. constant, exponential population growth or logistic population
growth) that best-fit each subtype data set, with model compar-
isons again undertaken using BF. Similarly, setting the prior on the
substitution rate, we estimated Bayesian skyline plots for each data
set. In all cases the convergence of parameters during the MCMC
was inspected with Tracer v.1.4 [19], with uncertainties depicted
as 95% highest probability (HPD) intervals. To provide an
independent assessment of the robustness of our analysis of
evolutionary dynamics we also estimated the TMRCA of each
data set using the Path-O-Gen program (available at http://tree.
bio.ed.ac.uk/software/pathogen/), which employs a linear regres-
sion of root-to-tip genetic distances against sampling time based on
the ML phylogenies described above.
HCV phylogeography
To evaluate how phylogenies are shaped by underlying
geography within Sa ˜o Paulo state we utilized the Bayesian
approach available in BEAST [19]. Specifically, we performed a
phylogeographic analysis using a standard continuous-time
Markov chain (CTMC) model with the Bayesian stochastic search
variable selection (BSSVS) procedure [21]. The three main
geographic locations of sampling (Metropolitan area of Sa ˜o Paulo,
Ribeira ˜o Preto and Sa ˜o Jose ´ do Rio Preto) were coded as
multistate characters and the most parsimonious description of
geographic spread was obtained by MCMC sampling from the
plausible set of trees using the procedures outlined above.
Fitting a power law to the sexual contact data
We estimated the extent of social interaction among the patients
in our data set as their total number of sexual contacts [22]. We
fitted a pure power law distribution model of the form P(k) > k
2a
to our data and estimated the minimal value of sexual contacts
above which the data follow a power law (xmin), and the maximum
likelihood estimator of the scaling exponent a using the goodness-
of-fit based method of [23] with the R v.2.10.0 program (http://
www.r-project.org/). The quality of fit was evaluated by a
Kolmogorov-Smirnov goodness-of-fit (K–S) test that compares
the D-statistic for the observed data to a critical D value estimated
for large n [24] from the expected power law distribution.
Estimating R
To allow a broad-scale comparison of growth dynamics across
HCV epidemics we obtained approximate estimates of the basic
Transmission Dynamics of HCV
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relation R=1+rD, where r is the population growth rate and D is
the mean time of infectiousness [25]. Growth rate (r) estimates
were obtained with BEAST from the best-fit demographic model
for each data set. Additionally, we estimated r using GENIE
(http://evolve.zoo.ox.ac.uk/software/Genie/) under the relation
r=rm, where m is the nucleotide substitution rate (subs/site/year)
and the composite parameter r (r/m) estimated from the ML
phylogeny, with branch lengths adjusted for date of sampling with
the TipDate program [26]. Parameter D is an estimator of the
generation time distribution (w(t)), which is a function that
describes the distribution of times between infections in a chain
of transmission [27]. Accurate proposals for w(t) depend on several
complex factors that are difficult to evaluate for a persistent virus
such as HCV, which causes fluctuating viral load levels during
chronic infections that may last several years [28,29]. Moreover,
the probability of virus transmission is expected to vary according
by risk factor. Therefore, instead of utilizing w(t), R was calculated
using a mean time of infectiousness (D) of 2, 5, 10, and 15 years,
which appear to cover a reasonable range of values. Importantly,
values of R inferred from phylogenetic trees may not relate linearly
to the number of infected people, and may also be strongly
affected by the variance on the number of potential infectious
contacts events. These limitations notwithstanding, agreements
between R estimated from viral phylogenies and from epidemi-
ological data have been noted [30].
Finally, the human population growth rate was approximated
using census data in time fitted to both exponential and logistic
curves, and by estimating the rate coefficients under the model
that best fit the data using the SPSS v.11.0.1 program (SPSS Inc.
Chicago, IL).
Results
HCV epidemiology and phylogeography
A total of 591 HCV sequences obtained from Sa ˜o Paulo State
were successfully amplified, sequenced and typed by phylogenetic
analysis using reference sequences obtained from the Los Alamos
HCV database. Genotype 1 was the most prevalent (70.5%),
comprising 51.3% of subtype 1b and 48.7% of HCV-1a samples.
Subtype 3a was the next most prevalent, representing 24.2% of all
samples. Genotype 2 included subtypes 2b and 2c and was found
at frequencies of 2.1% and 1.9% of the population, respectively.
Genotypes 4 and 5, not commonly found in Brazil, were detected
in five patients, one infected with the subtype 4a and four with 5a.
Subtypes only found in a small number of patients (2, 4 and 5)
were discarded for the subsequent analysis. Phylogenies of the
most common 1a, 1b and 3a subtypes also suggested different
demographic histories (Figure S1). Specifically, the HCV-1b
phylogeny possessed three distinct clusters comprising Brazilian
sequences, such that the same local epidemic is associated with
different 1b lineages. In contrast, there was no evidence for
phylogenetically distinct clusters in trees of subtypes 1a and 3a.
To reduce the effect of any phylogeographic structure on our
subsequent analysis of transmission dynamics we first excluded all
taxa that we suspected to be ‘‘migrant’’ due to their close
phylogenetic relationship to samples obtained from outside Brazil
(and taken from GenBank). In addition, we performed a Bayesian
analysis of phylogeographic structure, dividing our time-stamped
sequences into three main geographic sources: (i) the Metropolitan
area of Sa ˜o Paulo city, including patients from the Clinicas
Hospital, the Reference and Training Center (RTC), and Sa ˜o
Bernardo dos Campos (located in the outskirts of Sa ˜o Paulo), (ii)
Ribeira ˜o Preto, located in the west of Sa ˜o Paulo state some
317 km from the Sa ˜o Paulo metropolis, and, (iii)S a ˜o Jose ´ do Rio
Preto in northern Sa ˜o Paulo state, 443 km from the Sa ˜o Paulo city
and 205 km from Ribeira ˜o Preto. For each HCV genotype, the
root location with the highest posterior probability falls in the
metropolitan area of Sa ˜o Paulo city and is shown as black
branches in the maximum clade credibility (MCC) trees (Figure 1).
Although we found small phylogenetically distinct clusters of
sequences spreading in Ribeira ˜o Preto (sectors highlighted in
green) and Sa ˜o Jose ´ do Rio Preto (highlighted in blue) in all three
trees, overall there was clearly no segregation by region of
sampling. In addition, all region-specific clusters radiated at
approximately the same time as those from Sa ˜o Paulo (grey
concentric circles in Figure 1) suggesting that they should not
impact significantly on overall dynamics.
Time-scale of HCV emergence and dynamics in Sa ˜o Paulo
Key demographic and epidemiological parameters estimated for
all HCV subtypes, or collected from patients’ questionnaires, are
shown in Table 1. Importantly, our estimates for the TMRCA of
each subtype obtained under the best-fit demographic model
covered essentially the same range as those estimated by the
Bayesian skyline analysis, suggesting that these results are robust to
demographic history (see supplementary Table S1A to S1F for
details of the statistical analysis). Although HCV subtypes 1a, 1b
and 3a showed similar rates of nucleotide substitution, there were
significant differences among subtypes in both TMRCA and
population growth rate (Table 1). To infer how the demographic
history of each subtype changed through time we inferred
Bayesian skyline plots using a relaxed molecular clock and the
substitution rates estimated previously under the best-fitted model
of nucleotide substitution (that is, GTR+C+I+SRD112 for HCV-
1a, and 1b and HKY+SRD112 for HCV-3a). Although the 95%
HPD values for the skyline plots under the relaxed clock were too
wide for meaningful interpretation, those generated using a strict
clock gave a reasonable demographic signal (Figure 2 and S2).
Together, these evolutionary analyses suggest that HCV-1b was
the first subtype to enter Sa ˜o Paulo and which experienced rapid
population growth in the 1970’s, possibly spread by blood
transfusion and unsafe medical practices (the frequency of each
risk factor is given in Table 1). HCV-1b was followed by HCV-3a
in the mid 1960s (Table 1). HCV-1a was most likely the last
subtype to emerge and started growing exponentially in 1990’s,
after the end of paid blood donation and the onset of obligate
blood-donor screening (Figure 2), attaining the highest growth rate
of all (Table 1). Subtypes HCV-1a and 3a are known to dominate
IDU-associated infections in most industrialized countries. How-
ever, we found only 27% of HCV-1a and 20% of HCV-3a
infected individuals in our study to be at risk of exposure by IDU,
and a similar proportion, albeit with lower numbers, of NIDU
(Table 1). This last result is of relevance since people that use non-
injecting drugs (NIDU) are also at risk of HCV infection, mainly
due to crack and cocaine [31]. Indeed, approximately half of our
NIDU patients that reported sharing cocaine paraphernalia also
reported nasal bleeding (76 patients). Interestingly, most of our
NIDU used cocaine exclusively, with a small percentage (6%) also
reporting smoking crack, indicating that crack may not be
particularly important for HCV transmission among our study
population. Finally, because HCV prevalence in IDUs can reach
90% [32], it is possible that IDUs act as reservoirs that disseminate
the virus through the population as a whole.
We therefore explored the impact of injecting drug use on the
HCV transmission network. To do this we reconstructed the
ancestral mode of transmission across our subtype phylogenies
using ‘‘IDU’’, ‘‘non-IDU’’, and ‘‘unknown status’’ as character
Transmission Dynamics of HCV
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HCV transmission did not originate exclusively from IDU
(Figure 1). However, we did observe six small IDU clusters in
the HCV-1a phylogeny and one cluster in the HCV-1b tree
(highlighted red sectors in Figure 1). Moreover, since IDU
occurrence was higher in HCV-1a than HCV-3a and HCV-1b,
we also tested if IDU could explain the differences in growth rates
we observed. By excluding the IDUs from HCV-1a data set, we
observed that the exponential growth rate only increased from
0.51 to 0.56 and with overlapping 95% HPDs. We also observed
that 28 to 38% of our patients had unknown risk factors for HCV
transmission, which suggested that additional host-associated
factors should be considered as determinants of transmission
dynamics.
Dynamics associate with age structure of HCV patients
An important observation from our analysis of HCV population
dynamics was that viruses that emerged more recently – subtypes
1a and 3a –also experienced higher rates of population growth.
Strikingly, the year of birth of people infected by HCV-1a and 3a
was uni-modal, with modes of around 1954 and 1964 for HCV-3a
and HCV-1a, respectively (Figure 3). In marked contrast, the year
of birth structure of HCV-1b carriers was clearly multi-modal,
with three peaks roughly spaced according to decade-sized
Figure 1. Phylogeographic and IDU risk analysis. We show Maximum Clade Credibility (MCC) trees for the main HCV genotypes in Sa ˜o Paulo.
Branches are colored according to the geographic locality of sampling, with IDUs shown as red dots at the tips. The highest posterior probability for
the root of all trees revealed that the epicenter of HCV epidemics was the metropolitan area of Sa ˜o Paulo. Highlighted sectors indicate ancestral
nodes with posterior probability .50% located outside the metropolitan area of Sa ˜o Paulo (green in Ribeira ˜o Preto and blue in Sa ˜o Jose ´ do Rio
Preto). Branch lengths are scaled in years shown as concentric rings of 5 years. The grey concentric rings indicate that the epidemic expansion of
HCV-1a in Sa ˜o Jose ´ do Rio Preto and Ribeira ˜o Preto was synchronized with the growth in the metropolitan area of Sa ˜o Paulo. Most of the IDUs are
located within the HCV-1a and HCV-3a subtypes. Sectors highlighted in red indicate IDU clusters with posterior probability .50%. All trees depicted
non-IDU as the root state with the highest posterior probability.
doi:10.1371/journal.pone.0011170.g001
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that subtype HCV-1b has likely been circulating in Sa ˜o Paulo
since the beginning of the 20
th century, and because carriers
survive for long time periods following infection. Therefore, people
infected several decades ago were sampled during our study.
Host population size and social networks impact on HCV
transmission
The population dynamics of infectious agents are greatly
influenced by a variety of epidemiological factors, including host
population size and density, the spatial distribution of the host, and
the rate of contact between individuals [33,34]. As an initial
exploration of how these factors may impact HCV transmission
we investigated census population growth concurrent with the
spread of HCV in Sa ˜o Paulo. This analysis revealed a positive
relationship between human population increase and the growth
rates of each HCV subtype according to their time of origin
(Figure S3).
Since the rate of contact between infected and susceptible hosts
(i.e., the nodes of a transmission network) are crucial determinants
of epidemic dynamics [35,36], the number of connections per
highly-connected node should increase as a function of host
population density and size. Moreover, it reflects the intensifica-
tion of social interaction as measured by the number of sexual
contacts [22]. We therefore examined the dependency of the
cumulative frequency distribution P(k) on the total number of
sexual partners (k) obtained from questionnaires available for 492
of the 591 patients in our study group. Strikingly, we observed a
negative relationship of P(k) for increasingly higher values of the
number of reported sexual contacts (k), showing stereotypically
sequential decay on the number of sexual contacts (Figure 4A). We
then fitted the data to a pure power law distribution and estimated
the value of xmin=10 and the maximum likelihood value of the
scaling exponent a=2.15. Although other heavy-tailed distribu-
tions may explain our data [23], it conformed well to a power law
as shown by the significance of the K–S test statistic D=0.0254
(p,0.001, n=217, D-critical>0.0913), expounding the scale-free
nature of this HCV network. In general, values of k for most of the
cumulative frequency values of P(k) indicated a higher number of
Figure 2. Patterns of population growth for HCV1a, 1b and 3a.
The colored lines in the strict clock Bayesian skyline plots show the
superimposed median values (y-axis) of relative genetic diversity (Ne.g,
where Ne is the effective population size and g the inter-host
generation time) through time in years for each subtype. Vertical
arrows indicate the introduction of control measures in 1980 (end of
paid donation) and 1993 (implementation of screening for HCV in blood
banks) aimed to hamper HCV spread by blood products in Brazil.
doi:10.1371/journal.pone.0011170.g002
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3a and finally HCV-1b, and most strongly so at the heavy-tail side
of the curves (Figure 4A).
Since our patients did not identify sexual partners among others
in the cohort, we were not able to infer the exact topology of the
HCV network. Nevertheless, we examined the social, risk-related
and clinical factors at the two ends of the overall distribution (i.e.,
for all HCV carriers taken together to obtain robust parameter
estimates). By dividing all patients into two extreme log-binned
groups with ‘‘low-connectivity’’, defined as 5 or less sexual partners
(40% HCV-1b, 37% 1a and 23% 3a), and ‘‘high-connectivity’’,
reflecting 50 or more sexually partners (56% HCV-1a, 30% 3a
and 14% 1b), we found that greater sexual activity was also
associated with increased exposure to known HCV risk factors
(STD, drug use, tattooing and imprisonment) and specific
behaviors, such as unprotected sex (Figure 4B).
HIV-1 and HBV co-infection
HCV, HIV-1, and hepatitis B virus (HBV) share similar routes
of transmission and HCV infects 25 to 30% of HIV-infected
persons [37]. Although our sampling protocol was designed to
minimize the inclusion of persistent viral co-infections, we in fact
sampled 36 HIV-1 positive out of 878 HCV carriers. This 4.1%
prevalence was six times higher than the HIV-1 prevalence of
0.7% in the general Brazilian population [www.ias-2005.org/
admin/images/upload/533.pdf]. From the seventeen co-infected
samples sequenced here, there were nine patients infected by
HCV-1a, four by 1b and four by 3a. From these, 2.7% where at
the low-connectivity end of the HCV network and 6.1% were
located at the high-connectivity end, which also had several other
evident risk factors associated other than HIV-1 (Figure 4B).
Therefore, some small proportion of the increase in growth rate
we see in 1a and 3a compared to 1b could have been due to an
increased rate of HCV transmission due to HIV co-infection
(Figure 4B). Similarly, we found two HCV patients from a total of
494 to be HBV positive (0.4% prevalence, which was 10 times
lower than prevalence of 3.7% in metropolitan areas of Brazil
[38]. Both these individuals had medium connectivity (from 6 to
49 sexual partners) in the HCV network.
Discussion
Our study reveals that co-existing yet distinct epidemics of
different HCV subtypes circulate in Sa ˜o Paulo and among discrete
age-structured groups that are differently exposed to risk factors
for viral transmission. Subtypes HCV-1a and 3a also grew faster
than 1b during the last 20 years, and not reaching the plateau
observed in other localities [13]. Since our results are based on the
analysis of a large data set of randomly sampled sequences from a
one single regional epidemic, and backed by data on risk factors
and exposure behaviors, we believe that they are potentially a
more accurate reflection of HCV epidemic dynamics. We found
that the metropolitan area of Sa ˜o Paulo city was the epicenter of
HCV spread in the State, coinciding with it being also the
epicenter of human population growth during the 20th century.
Perhaps because HCV-1b reached high prevalence earlier in the
20th century it has been able to establish sustained transmission
among generations born from the 1940’s to the 1970’s. In
addition, subtype 1b was mainly transmitted through contaminat-
ed blood transfusion, which is not obviously associated with an
age-specific risk group, and the range of patients ages is expected
to be large in this case. This is reflected in the fact that 47% of
HCV-1b carriers born in the 1970’s (i.e., members of the last peak)
received blood transfusion at an early age. In contrast, HCV-3a
and subsequently HCV-1a colonized increasingly larger waves of
susceptible hosts. These results agree with previous studies of HCV
epidemics using smaller sample sizes showing that HCV-1a has
grown faster than 1b in many regions, including Brazil
[12,39,40,41,42]. While the nucleotide substitution rate we
obtained for HCV-1a (Table 1) was slightly higher than those
estimated for HCV in other localities [12], it is possible that this
signifies an increased strength of natural selection in this case, in
Figure 3. Viral and host age structure. Dotted color-filled distributions at the back of the figure show the relative densities of estimates of the
Time to the Most Recent Common Ancestor (TMRCA) of HCV-1a (red), HCV-1b (blue) and HCV-3a (green). The TMRCA relative densities (left y-axis)
depict the frequency normalized to unity of TMRCA values sampled during the MCMC runs in BEAST. Full line distributions in the foreground show
the percentage of HCV carriers that were born in a specific year (x-axis). Patient age distributions were color-coded in the same fashion as the TMRCA.
Horizontal arrows, connecting the mode of age of birth of patients with the TMRCA peak value for both HCV-3a and HCV-1a, show the temporal
correlation between each subtype origin of spread and the age of its carriers.
doi:10.1371/journal.pone.0011170.g003
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based estimates of the basic reproductive number (R) for the HCV-
1a and HCV-3a epidemics in Sa ˜o Paulo were higher than those
observed among IDUs in the United Kingdom [12], which also
exhibits a lower rate of census population growth during the last
century (see Figure S4 A and C). However, because there was no
clear distinction in risk association between subtypes HCV-3a and
HCV-1a, and because their growth rates were associated with
initial time of spread, it is clear that additional factors are needed
to fully explain the differing population dynamics of these
subtypes.
We therefore propose that the association between age modes
and times of subtype origin (horizontal arrows in Figure 3) is
largely explained by social factors that might confine HCV
transmission within specific age groups. Both an age group
restriction on transmission and the control measures implemented
in Brazil in 1980 and 1993 could help explain the slowdown in
HCV-1b transmission that occurred after 1985 (Figure 2). In
addition, age structure may explain more than just the epidemics
in Sa ˜o Paulo since the lower number of young adults (between 20
to 39 years of age) in the UK compared with Sa ˜o Paulo is
compatible with their difference in viral growth rates (Figure S4 B).
It is likely that age-structured waves of HCV carriers transmit the
virus among age-related susceptible hosts, perhaps due to
behavioral generation exclusion (i.e. a ‘‘generation gap’’). This
accords with the observation that people generally only have
significant contact with others like themselves (‘‘the homophylic
principle’’), which governs the emergence of assortative mixing in
social networks [43]. When assortative mixing occurs among
highly connected individuals (which can be thought of as ‘‘hubs’’),
such that nodes with many connections tend to be connected to
other nodes with many connections (i.e. preferential attachment),
then scale-free networks emerge such as the one we document here
[44,45]. Although blood transfusion and IDU enhance HCV
transmission, it has been also shown that ‘‘survival’’ sex work
among young people was the strongest predictor of elevated HCV
incidence in Canada [46]. Importantly, this justifies our sexual-
contact network analysis and also agrees with our results on age
stratification (Figure 3) and risk factors among highly connected
patients (Figure 4).
Importantly, although we do not currently understand to which
extent HCV is sexually transmitted, the association of high
connectivity and risk behavior in the HCV network, agrees with
genotype composition and age structuring, since 29% of the low-
connectivity patients were older than the high-connectivity group.
This also fits with the observed trend of higher rates of viral
population growth among younger age groups. The exception to
this was the obviously increased risk of blood transfusion among
the low-connectivity group (with a particularly high prevalence in
HCV-1b carriers), which also had a more even sex ratio compared
to the male-dominated high-connectivity end of the spectrum.
Moreover, both extreme groups had marked differences in other
factors, such as STD, IDU partners, tattooing, MSM, imprison-
ment, IDU, NIDU, not using condoms, etc., which could impact
on the rates of contact for HCV transmission (Figure 4B). These
data, together with the age-stratification data shown in Figure 3,
are strongly suggestive of assortative mixing.
In sum, the patterns obtained from clinical and sociologic data
suggest that each HCV subtype analyzed here is characterized by
different social networks. We therefore propose that increasing
population growth, with its knock-on effects on increased social
network connectivity and assortative mixing in urban settings, has
played a major role in increasing the transmission rate of HCV in
Sa ˜o Paulo and perhaps more widely.
Figure 4. Scale-free sexual contact network of HCV carriers. A)
The cumulative frequency distribution P(k) versus the number of
partners (k) shows that the low connectivity end of this network
(individuals with 5 or less sexual partners) is associated with a higher
prevalence of HIV-1b infected individuals compared to the high
connectivity heavy tail-end of the network, which is in turn more
frequently associated by HCV-1a and 3a carriers. B) Social, clinical and
transmission risk factors are shown in increasing frequency in relation to
the high-connectivity group that includes all HCV patients with 50 or
more sexual contacts (dark grey) compared to the low-connectivity
group that includes all HCV patients with 5 or less sexual contacts (light
grey). The final two columns on the right show a preponderance of
males with increased risk factors and behaviors. The high frequency of
blood transfusions among the low-connectivity group shows its
importance for HCV transmission among the general population at
large up until the early 1990’s.
doi:10.1371/journal.pone.0011170.g004
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Table S1 Bayes factor values obtained for substitution models
comparison.
Found at: doi:10.1371/journal.pone.0011170.s001 (0.07 MB
DOC)
Figure S1 Maximum likelihood phylogenetic trees of HCV
subtypes. Phylogenies were inferred using 335 sequences from
HCV-1a, 499 sequences from HCV-1b and 252 HCV-3a
sequences (i.e. a combination of those viruses sampled here and
those collected from GenBank). Sequences sampled in this work
are shown in phylogenies by colored branches, which indicate the
four distinct localities in the State of Sa ˜o Paulo: Ribeira ˜o Preto
(red), Sa ˜o Bernardo do Campo (green), Sa ˜o Paulo (blue) and Sa ˜o
Jose ´ do Rio Preto (yellow). There was an evident lack of
geographical structure in the data. Black branches correspond to
global reference sequences collated from GenBank. As Brazilian
sequences that fell within clusters of non-Brazilian sequences likely
signify recent migration they were excluded from the subsequent
phylodynamic analyses.
Found at: doi:10.1371/journal.pone.0011170.s002 (1.03 MB
TIF)
Figure S2 Bayesian skyline plots of the main subtypes found in
Sa ˜o Paulo: HCV-1a, HCV-3a and HCV-1b. Skyline plots
describe the mean change (bold line) in genetic diversity under
both the relaxed uncorrelated molecular clock (A, C, E) and strict
molecular clock (B, D and F) with values of the 95% of high
posterior density (HPD) shown in each case (light line).
Found at: doi:10.1371/journal.pone.0011170.s003 (0.88 MB TIF)
Figure S3 Relationship between population size in Sa ˜o Paulo
and viral dynamics. The graph shows the exponential population
growth in Sa ˜o Paulo State in the period 1920 to 2005 (left y-axis)
in millions of people and the increase of viral growth rate
(estimated using BEAST) during the same time period (right
y-axis). For comparison, the TMRCA for each subtype was
obtained also with Path-O-Gen, using the best ML phylogeny
inferred with GARLi. A summary of the change in time of HCV
growth rates and population size in Sa ˜o Paulo is shown in the
graph inserted in the upper left of the figure. Dots indicate the
growth rate values estimated for each subtype (shown with same
colors as in Figures 2 and 3) versus the log of the human
population size at the time of the most recent common ancestor
(TMRCA) of the subtype.
Found at: doi:10.1371/journal.pone.0011170.s004 (0.52 MB TIF)
Figure S4 Higher human population growth correlates with
higher rates of HCV growth. (A) Census population growth in Sa ˜o
Paulo (red dots) and the UK (blue dots) during the 20th Century.
The best-fit curve for both populations indicate linear growth in
the UK and exponential growth in the State of Sa ˜o Paulo. (B) By
partitioning the population of Brazil and the UK into age groups,
it appears that most of the growth in Brazil is taking place among
the age group that we found to be at a higher risk of infection by
HCV-1a and 3a (20–39 years-old). (C) The population growth rate
of HCV- 1a and HCV-3a was consistently higher in Brazil than in
the UK, suggesting that human population growth accelerates
HCV transmission.
Found at: doi:10.1371/journal.pone.0011170.s005 (0.62 MB TIF)
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